Novartis’ generics arm Sandoz has launched Zarzio, its biosimilar version of Amgen’s Neupogen, in the UK for the treatment of neutropenia in patients receiving chemotherapy or those infected with HIV.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback